Is cell replacement therapy finally moving from bench to bedside? The idea of "growing" new dopaminergic neurons to replace those lost to the disease has been a scientific dream for decades. In 2024, multiple Phase I/II trials using induced pluripotent stem cells (iPSCs) are reporting positive safety data, paving the way for larger efficacy studies in 2025. How do Stem Cell Research Trends...